Concordance between self‐reported and current hepatitis C virus infection status in a sample of people who inject drugs in Sydney and Canberra, Australia
Introduction Awareness of hepatitis C virus (HCV) status among people who inject drugs is critical to ensure linkage to care and reduce transmission risk. Testing pathways, confusion about results and possible reinfection raise potential for discordance between perceived and actual HCV status among...
Saved in:
Published in | Drug and alcohol review Vol. 40; no. 7; pp. 1349 - 1353 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Melbourne
John Wiley & Sons Australia, Ltd
01.11.2021
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Introduction
Awareness of hepatitis C virus (HCV) status among people who inject drugs is critical to ensure linkage to care and reduce transmission risk. Testing pathways, confusion about results and possible reinfection raise potential for discordance between perceived and actual HCV status among people who inject drugs. We evaluated self‐reported and serologically confirmed HCV status concordance among a sample of Australian people who inject drugs.
Methods
Data were collected in May–June 2018 from participants in Canberra and Sydney, Australia, who had injected drugs at least monthly in the past 6 months. Participants completed a structured interview assessing self‐reported HCV status and provided a dried blood spot sample for HCV RNA testing.
Results
Of 103 participants, 95% self‐reported ever receiving antibody testing, 58% of whom reported having received RNA testing. Seventy‐three percent of participants reported never having been told that they had HCV, 18% reported current infection and 9% did not know their current status. According to dried blood spot RNA testing, 20% were currently infected. Over a quarter of the sample (28%, n = 29) did not accurately report their HCV status, half of whom were unaware of a current infection.
Discussion and Conclusions
With over one‐quarter of the sample in our study not accurately reporting their current HCV status, our findings reinforce the importance of regular testing for active infection, and the need for improved health literacy on HCV antibody and RNA test results, HCV status post‐treatment and reinfection risk. |
---|---|
AbstractList | Awareness of hepatitis C virus (HCV) status among people who inject drugs is critical to ensure linkage to care and reduce transmission risk. Testing pathways, confusion about results and possible reinfection raise potential for discordance between perceived and actual HCV status among people who inject drugs. We evaluated self-reported and serologically confirmed HCV status concordance among a sample of Australian people who inject drugs.
Data were collected in May-June 2018 from participants in Canberra and Sydney, Australia, who had injected drugs at least monthly in the past 6 months. Participants completed a structured interview assessing self-reported HCV status and provided a dried blood spot sample for HCV RNA testing.
Of 103 participants, 95% self-reported ever receiving antibody testing, 58% of whom reported having received RNA testing. Seventy-three percent of participants reported never having been told that they had HCV, 18% reported current infection and 9% did not know their current status. According to dried blood spot RNA testing, 20% were currently infected. Over a quarter of the sample (28%, n = 29) did not accurately report their HCV status, half of whom were unaware of a current infection.
With over one-quarter of the sample in our study not accurately reporting their current HCV status, our findings reinforce the importance of regular testing for active infection, and the need for improved health literacy on HCV antibody and RNA test results, HCV status post-treatment and reinfection risk. IntroductionAwareness of hepatitis C virus (HCV) status among people who inject drugs is critical to ensure linkage to care and reduce transmission risk. Testing pathways, confusion about results and possible reinfection raise potential for discordance between perceived and actual HCV status among people who inject drugs. We evaluated self‐reported and serologically confirmed HCV status concordance among a sample of Australian people who inject drugs.MethodsData were collected in May–June 2018 from participants in Canberra and Sydney, Australia, who had injected drugs at least monthly in the past 6 months. Participants completed a structured interview assessing self‐reported HCV status and provided a dried blood spot sample for HCV RNA testing.ResultsOf 103 participants, 95% self‐reported ever receiving antibody testing, 58% of whom reported having received RNA testing. Seventy‐three percent of participants reported never having been told that they had HCV, 18% reported current infection and 9% did not know their current status. According to dried blood spot RNA testing, 20% were currently infected. Over a quarter of the sample (28%, n = 29) did not accurately report their HCV status, half of whom were unaware of a current infection.Discussion and ConclusionsWith over one‐quarter of the sample in our study not accurately reporting their current HCV status, our findings reinforce the importance of regular testing for active infection, and the need for improved health literacy on HCV antibody and RNA test results, HCV status post‐treatment and reinfection risk. Introduction Awareness of hepatitis C virus (HCV) status among people who inject drugs is critical to ensure linkage to care and reduce transmission risk. Testing pathways, confusion about results and possible reinfection raise potential for discordance between perceived and actual HCV status among people who inject drugs. We evaluated self‐reported and serologically confirmed HCV status concordance among a sample of Australian people who inject drugs. Methods Data were collected in May–June 2018 from participants in Canberra and Sydney, Australia, who had injected drugs at least monthly in the past 6 months. Participants completed a structured interview assessing self‐reported HCV status and provided a dried blood spot sample for HCV RNA testing. Results Of 103 participants, 95% self‐reported ever receiving antibody testing, 58% of whom reported having received RNA testing. Seventy‐three percent of participants reported never having been told that they had HCV, 18% reported current infection and 9% did not know their current status. According to dried blood spot RNA testing, 20% were currently infected. Over a quarter of the sample (28%, n = 29) did not accurately report their HCV status, half of whom were unaware of a current infection. Discussion and Conclusions With over one‐quarter of the sample in our study not accurately reporting their current HCV status, our findings reinforce the importance of regular testing for active infection, and the need for improved health literacy on HCV antibody and RNA test results, HCV status post‐treatment and reinfection risk. |
Author | Butler, Kerryn Larney, Sarah Sutherland, Rachel Starr, Mitchell Dietze, Paul M. Grebely, Jason Gibbs, Daisy Peacock, Amy |
Author_xml | – sequence: 1 givenname: Daisy orcidid: 0000-0002-2116-8190 surname: Gibbs fullname: Gibbs, Daisy email: daisy.gibbs@unsw.edu.au organization: UNSW Sydney – sequence: 2 givenname: Jason surname: Grebely fullname: Grebely, Jason organization: UNSW Sydney – sequence: 3 givenname: Rachel orcidid: 0000-0001-5337-1751 surname: Sutherland fullname: Sutherland, Rachel organization: UNSW Sydney – sequence: 4 givenname: Sarah orcidid: 0000-0002-5602-4963 surname: Larney fullname: Larney, Sarah organization: Université de Montréal and Centre de Recherche du CHUM – sequence: 5 givenname: Kerryn orcidid: 0000-0001-9173-6985 surname: Butler fullname: Butler, Kerryn organization: University of Sydney – sequence: 6 givenname: Paul M. orcidid: 0000-0001-7871-6234 surname: Dietze fullname: Dietze, Paul M. organization: The Burnet Institute – sequence: 7 givenname: Mitchell surname: Starr fullname: Starr, Mitchell organization: St Vincent's Hospital – sequence: 8 givenname: Amy orcidid: 0000-0002-5705-2026 surname: Peacock fullname: Peacock, Amy organization: UNSW Sydney |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33759276$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kcuKFDEUhoOMOD2jC19AAm4UrJlcKqnKsimvMCB4WRep5JSTpjopk5RN73wE976dT2K6e3QhmE1C8uXj8P8X6MwHDwg9puSKlnVtdbyinLXsHlrRWoqKc8nO0IoooSrBuDxHFyltCCFMCPYAnXPeCMUauUI_u-BNiFZ7A3iAvAPwOME0_vr-I8IcYgaLtbfYLDGCz_gWZp1ddgl3-JuLS8LOj2CyC-Vf1vl4gTVOejtPgMOIZwiH0-42lJdNQbGNy5cj9nFvPeyP_k77AWLUL_B6STnqyemH6P6opwSP7vZL9Pn1q0_d2-rm_Zt33fqmMlxwVglVU6toy5RoCRhTkqiH2tQDKGJ0SUWqQTYtlXxklgiplGnAGiLM0HLGGn6Jnp28cwxfF0i537pkYJq0h7CknglSNw1ppSzo03_QTViiL9MVqqRNG6oO1PMTZWJIKcLYz9Ftddz3lPSHxvrSWH9srLBP7ozLsAX7l_xTUQGuT8DOTbD_v6l_uf5wUv4Gk42jEA |
CitedBy_id | crossref_primary_10_1016_S2214_109X_23_00461_8 crossref_primary_10_1016_j_drugalcdep_2021_109050 crossref_primary_10_1016_j_drugpo_2022_103876 crossref_primary_10_3390_v14112463 |
Cites_doi | 10.7326/M15-0406 10.1080/14737159.2017.1400385 10.1111/j.1440-1746.2009.05910.x 10.1016/j.drugpo.2020.102837 10.1016/j.drugpo.2015.07.002 10.1111/add.14393 10.1111/jvh.13233 10.1016/j.drugalcdep.2010.11.018 10.1016/j.drugpo.2017.05.019 10.1186/s12889-017-4785-7 10.1080/23744235.2017.1334263 10.1371/journal.pone.0207226 10.1186/s41124-016-0016-6 10.1080/09540120701426524 10.1016/j.idc.2018.02.006 10.1016/S2468-1253(17)30284-4 10.1002/hep.31060 10.1111/j.1465-3362.2012.00502.x 10.1046/j.1360-0443.2002.00208.x 10.1111/j.1360-0443.2006.01543.x |
ContentType | Journal Article |
Copyright | 2021 Australasian Professional Society on Alcohol and other Drugs. 2021 Australasian Professional Society on Alcohol and other Drugs (APSAD) |
Copyright_xml | – notice: 2021 Australasian Professional Society on Alcohol and other Drugs. – notice: 2021 Australasian Professional Society on Alcohol and other Drugs (APSAD) |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QJ 7X8 |
DOI | 10.1111/dar.13282 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Applied Social Sciences Index & Abstracts (ASSIA) MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Applied Social Sciences Index and Abstracts (ASSIA) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Applied Social Sciences Index and Abstracts (ASSIA) MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Social Welfare & Social Work |
EISSN | 1465-3362 |
EndPage | 1353 |
ExternalDocumentID | 10_1111_dar_13282 33759276 DAR13282 |
Genre | shortCommunication Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GeographicLocations | Australia Canberra Australian Capital Territory Australia |
GeographicLocations_xml | – name: Australia – name: Canberra Australian Capital Territory Australia |
GrantInformation_xml | – fundername: National Health and Medical Research Council Career Development Fellowship funderid: 1112352; 1140938 – fundername: UNSW Sydney Scientia Fellowship – fundername: NIH grant NIDA funderid: R01DA1104470 – fundername: National Health and Medical Research Council Investigator Fellowship funderid: 1174630 – fundername: Australian Government Department of Health under the Drug and Alcohol Program – fundername: NIH grant NIDA grantid: R01DA1104470 |
GroupedDBID | --- ..I .3N .GA .Y3 0-V 05W 0R~ 10A 1L6 1OB 1OC 29G 2QV 31~ 33P 36B 3SF 3V. 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 6PF 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 88E 8FI 8FJ 8G5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AAPXX AASGY AAWTL AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABIVO ABJNI ABPVW ABQWH ABUWG ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGEJ ACGFO ACGFS ACGOF ACHQT ACMXC ACPOU ACSCC ACXBN ACXQS ADBBV ADBTR ADCVX ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADXPE ADZMN ADZOD AEEZP AEIGN AEIMD AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFKRA AFKVX AFPWT AHBTC AIACR AIAGR AITYG AIURR AIWBW AJBDE AJWEG ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS ALSLI ALUQN AMBMR AMYDB AQUVI ARALO ASOEW ATUGU AWYRJ AZBYB AZFZN AZQEC AZVAB BAFTC BDRZF BENPR BFHJK BHBCM BMXJE BPHCQ BROTX BRXPI BVXVI BY8 C45 CAG CCPQU CJNVE COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO DWQXO DXH EAD EAP EBC EBD EBS EJD EMB EMK EMOBN EPS ESX EV9 F00 F01 F04 F5P FEDTE FUBAC FYUFA G-S G.N GNUQQ GODZA GUQSH H.X HEHIP HF~ HGLYW HMCUK HVGLF HZ~ IX1 J0M J5H KBYEO KTM LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M0P M0T M1P M2M M2O M2S MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PADUT PALCI PQEDU PQQKQ PROAC PSQYO PSYQQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWI RX1 SAMSI SUPJJ SV3 TDBHL TEORI TFW UB1 UKHRP V8K W8V W99 WBKPD WHDPE WIH WIJ WIK WOHZO WOQ WQJ WRC WSUWO WXSBR XG1 XV2 ZZTAW ~IA ~WT CGR CUY CVF ECM EIF NPM AAMNL AAYXX ACRPL ACYXJ CITATION 7QJ 7X8 |
ID | FETCH-LOGICAL-c3532-5941d91829580ecc1324b4c4be90ca28269b678163f2d05699c7edc05cb832273 |
IEDL.DBID | DR2 |
ISSN | 0959-5236 |
IngestDate | Wed Dec 04 03:05:31 EST 2024 Thu Oct 10 20:29:12 EDT 2024 Fri Dec 06 02:17:11 EST 2024 Sat Sep 28 08:22:07 EDT 2024 Sat Aug 24 00:59:18 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | people who inject drug validity self-report dried blood spot hepatitis C |
Language | English |
License | 2021 Australasian Professional Society on Alcohol and other Drugs. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3532-5941d91829580ecc1324b4c4be90ca28269b678163f2d05699c7edc05cb832273 |
Notes | Daisy Gibbs MPH, Research Officer, Jason Grebely PhD, Professor, Rachel Sutherland PhD, Research Fellow, Sarah Larney PhD, Assistant Professor, Kerryn Butler PhD, Research Fellow, Paul M. Dietze PhD, Professor, Mitchell Starr BSc, Senior Hospital Specialist, Amy Peacock PhD, Senior Research Fellow. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-5602-4963 0000-0001-9173-6985 0000-0001-7871-6234 0000-0002-5705-2026 0000-0001-5337-1751 0000-0002-2116-8190 |
PMID | 33759276 |
PQID | 2595917196 |
PQPubID | 2033332 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_2504770866 proquest_journals_2595917196 crossref_primary_10_1111_dar_13282 pubmed_primary_33759276 wiley_primary_10_1111_dar_13282_DAR13282 |
PublicationCentury | 2000 |
PublicationDate | November 2021 2021-11-00 20211101 |
PublicationDateYYYYMMDD | 2021-11-01 |
PublicationDate_xml | – month: 11 year: 2021 text: November 2021 |
PublicationDecade | 2020 |
PublicationPlace | Melbourne |
PublicationPlace_xml | – name: Melbourne – name: Australia – name: Surry Hills |
PublicationTitle | Drug and alcohol review |
PublicationTitleAlternate | Drug Alcohol Rev |
PublicationYear | 2021 |
Publisher | John Wiley & Sons Australia, Ltd Wiley Subscription Services, Inc |
Publisher_xml | – name: John Wiley & Sons Australia, Ltd – name: Wiley Subscription Services, Inc |
References | 2011; 116 2015; 163 2015; 26 2009; 24 2018; 3 2016; 1 2013; 32 2017; 47 2002; 97 2017; 17 2020; 83 2017; 49 2020; 71 2019 2020; 27 2018 2019; 114 2017 2008; 20 2018; 32 2006; 101 2018; 13 Commonwealth of Australia (e_1_2_8_26_1) 2017 e_1_2_8_24_1 e_1_2_8_25_1 e_1_2_8_3_1 World Health Organization (e_1_2_8_7_1) 2017 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_9_1 Peacock A (e_1_2_8_17_1) 2018 e_1_2_8_8_1 IBM Corp (e_1_2_8_18_1) 2017 e_1_2_8_20_1 e_1_2_8_21_1 e_1_2_8_22_1 e_1_2_8_23_1 Heard S (e_1_2_8_6_1) 2019 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_14_1 e_1_2_8_15_1 e_1_2_8_16_1 e_1_2_8_10_1 e_1_2_8_11_1 e_1_2_8_12_1 |
References_xml | – volume: 116 start-page: 52 year: 2011 end-page: 6 article-title: Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs publication-title: Drug Alcohol Depend – volume: 1 start-page: 8 year: 2016 article-title: Concordance between self‐reported and measured HIV and hepatitis C virus infection status among people who inject drugs in Germany publication-title: Hepatol Med Policy – volume: 71 start-page: 686 year: 2020 end-page: 721 article-title: Guidance 2019 update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America recommendations for testing, managing, and treating hepatitis C virus infection publication-title: Hepatology – volume: 32 start-page: 208 year: 2013 end-page: 10 article-title: Concordance between self‐reported and actual hepatitis C virus infection status in a cohort of people who inject drugs publication-title: Drug Alcohol Rev – volume: 32 start-page: 269 year: 2018 end-page: 79 article-title: Elimination of hepatitis C virus in Australia publication-title: Infect Dis Clin North Am – volume: 49 start-page: 728 year: 2017 end-page: 36 article-title: Prevalence of hepatitis C and pre‐testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange program publication-title: Infect Dis – volume: 47 start-page: 51 year: 2017 end-page: 60 article-title: Research priorities to achieve universal access to hepatitis C prevention, management and direct‐acting antiviral treatment among people who inject drugs publication-title: Int J Drug Policy – volume: 114 start-page: 150 year: 2019 end-page: 66 article-title: Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs publication-title: Addiction – volume: 17 start-page: 757 year: 2017 article-title: Estimating the number of people who inject drugs in Australia publication-title: BMC Public Health – volume: 83 year: 2020 article-title: Estimating the consensus hepatitis C cascade of care among people who inject drugs in Australia: pre and post availability of direct acting antiviral therapy publication-title: Int J Drug Policy – volume: 17 start-page: 1109 year: 2017 end-page: 15 article-title: Hepatitis C point‐of‐care diagnostics: in search of a single visit diagnosis publication-title: Expert Rev Mol Diagn – volume: 13 year: 2018 article-title: Beyond interferon side effects: what residual barriers exist to DAA hepatitis C treatment for people who inject drugs? publication-title: PLoS One – volume: 27 start-page: 281 year: 2020 end-page: 93 article-title: Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre‐ and post‐universal access to direct‐acting antiviral treatment in Australia: the LiveRLife study publication-title: J Viral Hepat – volume: 3 start-page: 125 year: 2018 end-page: 33 article-title: Restrictions for reimbursement of interferon‐free direct‐acting antiviral drugs for HCV infection in Europe publication-title: Lancet Gastroenterol Hepatol – year: 2017 – volume: 97 start-page: 1289 year: 2002 end-page: 94 article-title: The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users publication-title: Addiction – volume: 20 start-page: 116 year: 2008 end-page: 23 article-title: Experience of hepatitis C testing among injecting drug users in Sydney, Australia publication-title: AIDS Care – year: 2018 – year: 2019 – volume: 101 start-page: 1499 year: 2006 end-page: 508 article-title: Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia publication-title: Addiction – volume: 163 start-page: 215 year: 2015 end-page: 23 article-title: Restrictions for Medicaid reimbursement of sofosbuvir for the treatment of hepatitis C virus infection in the United States publication-title: Ann Intern Med – volume: 26 start-page: 984 year: 2015 end-page: 91 article-title: Liver disease knowledge and acceptability of non‐invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: the LiveRLife study publication-title: Int J Drug Policy – volume: 24 start-page: 1648 year: 2009 end-page: 54 article-title: The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997–2006 publication-title: J Gastroenterol Hepatol – ident: e_1_2_8_9_1 doi: 10.7326/M15-0406 – ident: e_1_2_8_11_1 doi: 10.1080/14737159.2017.1400385 – ident: e_1_2_8_3_1 doi: 10.1111/j.1440-1746.2009.05910.x – ident: e_1_2_8_10_1 doi: 10.1016/j.drugpo.2020.102837 – ident: e_1_2_8_13_1 doi: 10.1016/j.drugpo.2015.07.002 – ident: e_1_2_8_5_1 doi: 10.1111/add.14393 – volume-title: Global hepatitis report 2017 year: 2017 ident: e_1_2_8_7_1 contributor: fullname: World Health Organization – ident: e_1_2_8_20_1 doi: 10.1111/jvh.13233 – ident: e_1_2_8_12_1 doi: 10.1016/j.drugalcdep.2010.11.018 – ident: e_1_2_8_23_1 doi: 10.1016/j.drugpo.2017.05.019 – ident: e_1_2_8_22_1 doi: 10.1186/s12889-017-4785-7 – ident: e_1_2_8_15_1 doi: 10.1080/23744235.2017.1334263 – ident: e_1_2_8_19_1 doi: 10.1371/journal.pone.0207226 – ident: e_1_2_8_14_1 doi: 10.1186/s41124-016-0016-6 – ident: e_1_2_8_16_1 doi: 10.1080/09540120701426524 – volume-title: Illicit drug reporting system (IDRS) interviews: background and methods year: 2018 ident: e_1_2_8_17_1 contributor: fullname: Peacock A – ident: e_1_2_8_21_1 doi: 10.1016/j.idc.2018.02.006 – ident: e_1_2_8_8_1 doi: 10.1016/S2468-1253(17)30284-4 – ident: e_1_2_8_25_1 doi: 10.1002/hep.31060 – ident: e_1_2_8_4_1 doi: 10.1111/j.1465-3362.2012.00502.x – volume-title: IBM SPSS statistics for Windows, version 25.0 year: 2017 ident: e_1_2_8_18_1 contributor: fullname: IBM Corp – volume-title: National hepatitis C testing policy v1.2 year: 2017 ident: e_1_2_8_26_1 contributor: fullname: Commonwealth of Australia – volume-title: Australian needle syringe program survey national data eport 2014–2018: Prevalence of HIV, HCV and injecting and sexual behaviour among NSP attendees year: 2019 ident: e_1_2_8_6_1 contributor: fullname: Heard S – ident: e_1_2_8_24_1 doi: 10.1046/j.1360-0443.2002.00208.x – ident: e_1_2_8_2_1 doi: 10.1111/j.1360-0443.2006.01543.x |
SSID | ssj0002552 |
Score | 2.3707387 |
Snippet | Introduction
Awareness of hepatitis C virus (HCV) status among people who inject drugs is critical to ensure linkage to care and reduce transmission risk.... Awareness of hepatitis C virus (HCV) status among people who inject drugs is critical to ensure linkage to care and reduce transmission risk. Testing pathways,... IntroductionAwareness of hepatitis C virus (HCV) status among people who inject drugs is critical to ensure linkage to care and reduce transmission risk.... INTRODUCTIONAwareness of hepatitis C virus (HCV) status among people who inject drugs is critical to ensure linkage to care and reduce transmission risk.... |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1349 |
SubjectTerms | Australia - epidemiology Blood Confusion dried blood spot Drug Users Drugs Health literacy Hepacivirus Hepatitis C Hepatitis C - diagnosis Hepatitis C - drug therapy Hepatitis C - epidemiology Humans Infections people who inject drug Risk reduction Self Report Substance Abuse, Intravenous - drug therapy Substance Abuse, Intravenous - epidemiology validity |
Title | Concordance between self‐reported and current hepatitis C virus infection status in a sample of people who inject drugs in Sydney and Canberra, Australia |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fdar.13282 https://www.ncbi.nlm.nih.gov/pubmed/33759276 https://www.proquest.com/docview/2595917196 https://search.proquest.com/docview/2504770866 |
Volume | 40 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELWqnnopUAosLGioEOJAVtnE-bB6qrZUVaX2UKjoASnyV2jVKqmSDaic-Anc--_4JczYSaAgJMRtFU_WifNmPOM8vzD2wsxLVSZYpmo-NwHnOg8kTvRBmMuEPjpqUrfD-_Ao3T_hB6fJ6QrbHvbCeH2IccGNPMPFa3JwqdpfnBzL7BmWUjnF33mcEZ1v9_indBSmypHX2RNUbKW9qhCxeMYzb89FfySYt_NVN-Hs3WEfhkv1PJOLWbdUM_3lNxXH_7yXu2y9T0RhxyPnHlux1Qab-t268N5elrKx8BKGA3VzcZ_dLGqSvTSEFOgZXtCi7fev3_zLB2tAVga0V32CM0uE7eV5Cwv4dN50LQzkLzwP01x3ACS0kkSKoS7BM9rh81mNLbRGBKbpPjqzt9emstfu_xeSeGmNfA3jWs0mO9l7826xH_Rfdwh0nMRYAQtEh8DyRiR5iEDC--eKa66sCLXEsUiFwpkU88UyMpimCaEza3SYaEVRKIsfsNWqruwjBgqBlodGRipWPMowcKp5mhjOEaGljuMJ2xqec3HlRTyKofjBoS_c0E_YdEBA0ftxW2BxmGBBi2Fqwp6PzeiB9FpFVrbuyCbkGXaaos1Dj5yxlxiBKaIMW1655__37ovdnWP34_G_mz5haxFRbNzWyClbXTadfYo50lI9c87wA58_Dag |
link.rule.ids | 314,780,784,1375,27924,27925,46294,46718 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqcigXXuWxsJQpQogDWWUTO4klLtW21dLXobSiFxT5FVoVJSjZgMqJn8Cdf8cvYWwnKQUhIW5RPIk33m_G8znjL4Q809NCFgxpqqJTHVCqskDgRB-EmWD2o6M6cTu89w-S-THdOWEnS-RVvxfG60MMC27WM1y8tg5uF6R_8XLk2RPkUhkG4Gvo7lNb0LV5eCkehcly5JX2uKVbSacrZOt4hkuvzkZ_pJhXM1Y35WzfJO_6H-srTc4n7UJO1JffdBz_92lukRtdLgobHjy3yZIp75Cx37ALb82HQtQGnkN_oqrPV8n3WWWVL7UFC3RFXtCg7Y-v3_z7B6NBlBqUF36CU2NrthdnDczg01ndNtDXf-F1mOm6EyCgEVanGKoCfFE7fD6tsMUuE4Gu2_fO7M2FLs2Fu_9M2NK0WryEYbnmLjne3jqazYPuAw-BilmMJJgjQDgyHM6yELGEz08lVVQaHiqBY5FwiZMppoxFpDFT41ylRquQKWkDURrfI8tlVZoHBCRiLQu1iGQsaZRi7JTThGlKEaSFiuMRedr_0flHr-OR9_wHhz53Qz8i4x4CeefKTY78kCGnxUg1IutDMzqhfbMiSlO11iakKXaaoM19D52hlzhOGY9SbHnhAPD37vPNjUN38PDfTZ-QlfnR_l6-9_pg9xG5HtmKG7dTckyWF3VrHmPKtJBrzjN-AneQEck |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIiEuUMqjSxc6IIQ4kFU2sZNYnKpdVuVVoUJFD0iRX6FVUVIlG6r2xE_gzr_jlzC2k0BBSIhbZE_i2JkZz2ePvxDyUE8LWTCEqYpOdUCpygKBE30QZoLZn47qxJ3wfr2b7OzTFwfsYIU87c_CeH6IYcHNWobz19bAT3Txi5EjzJ4glMrQ_16iScQtcf587yd3FMbKkSfa4xZtJR2tkE3jGW69OBn9EWFeDFjdjLO4Rj707-oTTY4n7VJO1PlvNI7_2Zk1crWLRGHbq851smLKdTL2x3XhvflUiNrAI-gLqvr4Bvk2qyzvpbaqAl2KFzQo-_3LV7_7YDSIUoPytE9waGzG9vKogRl8PqrbBvrsL7wP41xXAAIaYVmKoSrAp7TD6WGFNXaRCHTdfnRib890ac7c82fCJqbV4gkMizU3yf7i2bvZTtD93iFQMYsRAnNUD474hrMsRE3C_lNJFZWGh0rgWCRc4lSKAWMRaYzTOFep0SpkSlo3lMa3yGpZlWaDgERNy0ItIhlLGqXoOeU0YZpSVNFCxfGIPOi_c37iWTzyHv3g0Odu6Edk3GtA3hlykyM6ZIho0U-NyP2hGk3Q7quI0lStlQlpio0mKHPba87QShynjEcp1jx23__vzefz7T13ceffRbfI5TfzRf7q-e7LTXIlsuk27pjkmKwu69bcxXhpKe85u_gBO7wQeA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Concordance+between+self%E2%80%90reported+and+current+hepatitis+C+virus+infection+status+in+a+sample+of+people+who+inject+drugs+in+Sydney+and+Canberra%2C+Australia&rft.jtitle=Drug+and+alcohol+review&rft.au=Gibbs%2C+Daisy&rft.au=Grebely%2C+Jason&rft.au=Sutherland%2C+Rachel&rft.au=Larney%2C+Sarah&rft.date=2021-11-01&rft.issn=0959-5236&rft.eissn=1465-3362&rft.volume=40&rft.issue=7&rft.spage=1349&rft.epage=1353&rft_id=info:doi/10.1111%2Fdar.13282&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_dar_13282 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0959-5236&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0959-5236&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0959-5236&client=summon |